A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Clinical trial NCT05225207 · COMPLETED

Trial details

NCT number: NCT05225207
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Liver Neoplasms Carcinoma, Hepatocellular

Start date: 2019-05-28
Primary completion: 2022-01-31
Enrollment: 658

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.